J.W. Cole Advisors, Inc. Trans Medics Group, Inc. Transaction History
J.W. Cole Advisors, Inc.
- $2.33 Billion
- Q3 2024
A detailed history of J.W. Cole Advisors, Inc. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 10,257 shares of TMDX stock, worth $775,736. This represents 0.07% of its overall portfolio holdings.
Number of Shares
10,257
Previous 14,305
28.3%
Holding current value
$775,736
Previous $2.15 Million
25.26%
% of portfolio
0.07%
Previous 0.1%
Shares
5 transactions
Others Institutions Holding TMDX
# of Institutions
397Shares Held
31.7MCall Options Held
466KPut Options Held
286K-
Vanguard Group Inc Valley Forge, PA3.6MShares$272 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$200 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.44MShares$109 Million2.22% of portfolio
-
State Street Corp Boston, MA1.27MShares$96.3 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.09MShares$82.7 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.41B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...